Home › Funds › Opaleye Management Inc. › ETON
Opaleye Management Inc. position in ETON
ETON PHARMACEUTICALS INC COM · Health Care
Opaleye Management Inc. reported holding 2,860,000 shares of ETON (ETON PHARMACEUTICALS INC COM) in its Q2 2026 13F filing — a position valued at US$103.5M, representing 9.38% of its reported portfolio and ranking #2 among its reported holdings. Opaleye Management Inc. has disclosed ETON holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Opaleye Management Inc.'s ETON position evolved
Opaleye Management Inc. first disclosed a stake in ETON in Q3 2023 at 2,430,270 shares (US$10.1M). The position peaked in Q2 2026 at 2,860,000 shares, worth US$103.5M. Across 12 filings, Opaleye Management Inc. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q2 2026) shows 2,860,000 shares valued at US$103.5M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.43M | $10.13M | New |
| Q4 2023 | 2.53M | $11.08M | Add |
| Q1 2024 | 2.45M | $9.17M | Reduce |
| Q2 2024 | 2.40M | $7.88M | Reduce |
| Q3 2024 | 2.78M | $16.68M | Add |
| Q4 2024 | 2.85M | $37.99M | Add |
| Q1 2025 | 2.85M | $37.02M | Hold |
| Q2 2025 | 2.86M | $40.76M | Hold |
| Q3 2025 | 2.86M | $62.15M | Hold |
| Q4 2025 | 2.86M | $48.36M | Hold |
| Q1 2026 | 2.86M | $70.58M | Hold |
| Q2 2026 | 2.86M | $103.53M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ETON and 13F data
ETON (ETON PHARMACEUTICALS INC COM) is a Health Care company. 64 other funds we track also report a position in ETON — the largest reported positions include EcoR1 Capital, LLC (US$78.6M), Nantahala Capital Management, LLC (US$42.6M), National Philanthropic Trust (US$17.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ETON
- EcoR1 Capital, LLC 2.17M sh · $78.62M · Q2 2026
- Nantahala Capital Management, LLC 1.18M sh · $42.57M · Q2 2026
- National Philanthropic Trust 492.11K sh · $17.81M · Q2 2026
- Westside Investment Management, Inc. 431.16K sh · $15.61M · Q2 2026
- Pillsbury Lake Capital LLC 387.16K sh · $14.02M · Q2 2026
- Panoramic Capital, LLC 208.19K sh · $7.54M · Q2 2026
- Lumbard & Kellner, LLC 175.91K sh · $6.37M · Q2 2026
- CANNELL CAPITAL LLC 170.75K sh · $6.18M · Q2 2026
- Prospect Capital Advisors, LLC 157.20K sh · $5.69M · Q2 2026
- Aristides Capital LLC 145.41K sh · $5.26M · Q2 2026
- PRELUDE CAPITAL MANAGEMENT, LLC 137.57K sh · $4.98M · Q2 2026
More on Opaleye Management Inc.
FAQ
How long has Opaleye Management Inc. held ETON?
Opaleye Management Inc. has disclosed ETON holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Opaleye Management Inc.'s current position in ETON?
As of Q2 2026, Opaleye Management Inc. holds 2.86M shares of ETON (ETON PHARMACEUTICALS INC COM), valued at $103.53M, representing 9.38% of its reported portfolio and ranking #2.
Has Opaleye Management Inc. been buying or selling ETON?
In the latest 13F filing (Q2 2026), Opaleye Management Inc. held unchanged its position in ETON. The position peaked in Q2 2026 at 2.86M shares.
Which other funds hold ETON?
Other major institutional holders of ETON include EcoR1 Capital, LLC, Nantahala Capital Management, LLC, National Philanthropic Trust, among 64 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.